from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2058c/rpmB2

LFCtreatmentdescriptionclass of inhibitor

0.108

Amikacinug/mL Amikacintranslation

0.758

Cap5-10ug/mL Capreomycintranslation

0.433

Rox10-50 ug/mL Roxithromycintranslation

0.610

SM2-5 ug/mL Streptomycintranslation

-1.100

Tet5-10 ug/mL Tetracyclinetranslation

0.000

Rif0.2-5ug/mL Rifampicintranscription

0.188

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.420

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.401

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.085

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.016

Clofazimine10-13 ug/mL Clofaziminerespiration

0.224

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.359

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.099

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.248

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.686

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.405

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.198

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.151

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.839

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.162

KCN5-20 ug/mL Potassium cyaniderespiration

0.940

NaN30.2-2 mM Sodium aziderespiration

0.220

Nigericin50 uM Nigericinrespiration

0.278

TRC10-150 ug/mL Triclosanrespiration

-0.418

TRZ10-25 ug/mL Thioridazinerespiration

3.976

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.322

menadione6-10 ug/mL Menadionerespiration

0.148

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.078

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.006

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.375

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.299

NRP_1Non-replicating persistence stage 1dosRassociated

-0.212

Amp0.2mg/mL AmpicillincellWall

0.042

Cephalexin20-100 ug/mL CephalexincellWall

0.466

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.463

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.196

EMB10-20 ug/mL EthambutolcellWall

-0.162

Eta12-40 ug/mL EthionamidecellWall

-0.242

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.160

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.022

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.488

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.073

BZA0.12 mg/mL BenzamidearomaticAmides

-0.144

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.031

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.398

H2O24 mM hydrogen peroxideDNAdamaging

0.195

Levo10 ug/mL LevofloxacinDNAdamaging

-0.133

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.133

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.006

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.033

UVUV-irradiationDNAdamaging

1.335

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.333

Antimycin12.5-50 ug/mL Antimycin A?

0.199

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.005

PA_110-50 ug/mL Antitubercular compound PA-1?

0.163

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.383

PA8240.2-2 ug/mL PA-824?

-2.978

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-2.358

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.348

Verapamil50 uM Verapamil?

0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

0.296

methoxatin10-20 ug/mL Methoxatin?